{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:58:35Z","timestamp":1785455915390,"version":"3.56.0"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,14]]},"DOI":"10.18632\/oncotarget.9282","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T12:12:06Z","timestamp":1462968726000},"page":"36539-36550","source":"Crossref","is-referenced-by-count":39,"title":["p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Dandan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"},{"name":"Department of Basic Medicine, Kangda College of Nanjing Medical University, Lianyungang, Jiangsu Province 222000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulan","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Su","sequence":"additional","affiliation":[{"name":"Center for Clinical Pathology and Laboratory, Affiliated Hospital of Yifu, Nanjing Medical University, Nanjing, Jiangsu Province 211166, China"},{"name":"Department of Pathology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"},{"name":"Center for Clinical Pathology and Laboratory, Affiliated Hospital of Yifu, Nanjing Medical University, Nanjing, Jiangsu Province 211166, China"},{"name":"Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu Province 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ijc.29558","article-title":"NF-kappaB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma","volume":"137","author":"Hennessey","year":"2015","journal-title":"Int J Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Brakenhoff","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.oraloncology.2010.03.007","article-title":"Current trends and future perspectives in the surgical management of oral cancer","volume":"46","author":"Bhandari","year":"2010","journal-title":"Oral Oncol"},{"key":"4","first-page":"4","article-title":"Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer","volume":"7","author":"Chen","year":"2013","journal-title":"J Carcinog Mutagen"},{"key":"5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Nieto","year":"2009","journal-title":"Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc3265","article-title":"To differentiate or not\u2014routes towards metastasis","volume":"12","author":"Brabletz","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","article-title":"IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway","volume":"9","author":"Kumar","year":"2011","journal-title":"Mol Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/cyto.2001.0982","article-title":"Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data","volume":"16","author":"Lauta","year":"2001","journal-title":"Cytokine"},{"key":"10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2010.02.019","article-title":"Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells","volume":"295","author":"Li","year":"2010","journal-title":"Cancer Lett"},{"key":"11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymthe.2006.08.031","article-title":"Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and\/or MEK in head and neck squamous cell carcinomas","volume":"5","author":"Chen","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"12","first-page":"2761","article-title":"Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma","volume":"25","author":"Hormann","year":"2005","journal-title":"Anticancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/cncr.23615","article-title":"Interleukin-6 predicts recurrence and survival among head and neck cancer patients","volume":"113","author":"Teknos","year":"2008","journal-title":"Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","article-title":"Interleukin-6 and its receptor in cancer: implications for translational therapeutics","volume":"110","author":"Kurzrock","year":"2007","journal-title":"Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pros.20057","article-title":"Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells","volume":"60","author":"Kuo","year":"2004","journal-title":"Prostate"},{"key":"16","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.1009472107","article-title":"TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer","volume":"107","author":"Sordella","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Fingar","year":"2012","journal-title":"Biochem J"},{"key":"18","doi-asserted-by":"crossref","first-page":"14939","DOI":"10.1074\/jbc.M900097200","article-title":"p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling","volume":"284","author":"Blenis","year":"2009","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/138920311795659407","article-title":"Role of mTOR signaling in tumor cell motility, invasion and metastasis","volume":"12","author":"Huang","year":"2011","journal-title":"Curr Protein Pept Sci"},{"key":"20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.10398","article-title":"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines","volume":"99","author":"Van Waes","year":"2002","journal-title":"Int J Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1158\/1078-0432.CCR-12-2716","article-title":"PI3K\/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer","volume":"19","author":"Van Waes","year":"2013","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1158\/0008-5472.CAN-07-6302","article-title":"p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells","volume":"68","author":"Wong","year":"2008","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10585-006-9031-0","article-title":"Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis","volume":"23","author":"Chen","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3892\/or.2012.1846","article-title":"Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma","volume":"28","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"key":"25","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.18632\/oncotarget.2253","article-title":"Dual PI3K\/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma","volume":"5","author":"Colomer","year":"2014","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/ijc.23324","article-title":"A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX\/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas","volume":"122","author":"Chen","year":"2008","journal-title":"Int J Cancer"},{"key":"27","first-page":"5175","article-title":"Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT\/mTOR\/STAT3 signaling","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ymgme.2014.11.017","article-title":"Targeting novel signaling pathways for resistant acute myeloid leukemia","volume":"114","author":"Eklund","year":"2015","journal-title":"Mol Genet Metab"},{"key":"29","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/sj.onc.1209691","article-title":"Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways","volume":"25","author":"Huang","year":"2006","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways","volume":"71","author":"Evers","year":"2011","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2011-02-331579","article-title":"S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation","volume":"118","author":"McCarty","year":"2011","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1440-1711.2000.00928.x","article-title":"Cellular function of p70S6K: a role in regulating cell motility","volume":"78","author":"Crouch","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1210\/en.2005-1404","article-title":"Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells","volume":"147","author":"Wong","year":"2006","journal-title":"Endocrinology"},{"key":"34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/sj.bjc.6604735","article-title":"Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma","volume":"99","author":"Chen","year":"2008","journal-title":"Br J Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.10837","article-title":"A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4161\/cbt.20989","article-title":"Perifosine enhances mTORC1-targeted cancer therapy by activation of GSK3beta in NSCLC cells","volume":"13","author":"Wang","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"37","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s10620-013-2735-5","article-title":"AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers","volume":"58","author":"Wang","year":"2013","journal-title":"Dig Dis Sci"},{"key":"38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1073\/pnas.0810956106","article-title":"The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations","volume":"106","author":"Reddy","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-3-23","article-title":"Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells","volume":"3","author":"Cochran","year":"2003","journal-title":"BMC Cancer"},{"key":"40","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1158\/0008-5472.CAN-05-0924","article-title":"Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells","volume":"65","author":"Cochran","year":"2005","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0960-9822(02)00762-5","article-title":"Identification of a conserved motif required for mTOR signaling","volume":"12","author":"Blenis","year":"2002","journal-title":"Curr Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:12:02Z","timestamp":1589231522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":41,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,6,14]]}},"alternative-id":["9282","27174914"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9282","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}